Stockscreener 앱 받기
0.27
8.16%
-0.024
시간 외 거래:
.27
전일 마감가:
$0.294
열려 있는:
$0.281
하루 거래량:
969.60K
Relative Volume:
0.77
시가총액:
$7.31M
수익:
$1,000
순이익/손실:
$-14.08M
주가수익비율:
-0.2445
EPS:
-1.1043
순현금흐름:
$-7.05M
1주 성능:
-12.62%
1개월 성능:
-26.77%
6개월 성능:
-79.70%
1년 성능:
-93.50%
1일 변동 폭
$0.2608
$0.2917
1주일 범위
$0.2608
$0.3459
52주 변동 폭
$0.2608
$4.1955
Ernexa Therapeutics Inc Stock (ERNA) Company Profile
명칭
Ernexa Therapeutics Inc
전화
(617) 798-6700
주소
1035 CAMBRIDGE STREET, CAMBRIDGE
Compare ERNA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ERNA
Ernexa Therapeutics Inc
|
0.27 | 7.96M | 1,000 | -14.08M | -7.05M | -1.1043 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Ernexa Therapeutics Inc 주식(ERNA)의 최신 뉴스
Resistance Check: Is PAVmed Inc stock a value trap2026 Key Lessons & Precise Buy Zone Tips - baoquankhu1.vn
AI Stocks: Why is Ernexa Therapeutics Inc stock going upTrade Risk Report & High Conviction Buy Zone Alerts - baoquankhu1.vn
Ernexa Therapeutics IncMay Offer Up To $50 Million Of SecuritiesSEC Filing - TradingView
Ernexa Therapeutics Inc. 2025 Annual Report: Synthetic Allogeneic iMSC Therapy, Business Overview, Key Risks, and Patent Portfolio - Minichart
Ernexa Therapeutics 2025 10-K: $0.0M Revenue, Net Loss $(14.08)M - TradingView
Aug Wrap: Is Ernexa Therapeutics Inc exposed to currency risksPortfolio Growth Summary & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Ernexa Therapeutics Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Aug Sentiment: What is Ernexa Therapeutics Incs book value per shareJuly 2025 Price Swings & Accurate Entry/Exit Alerts - baoquankhu1.vn
Breakout Move: Is Ernexa Therapeutics Inc a strong candidate for buy and holdJuly 2025 Institutional & Pattern Based Trade Signal System - baoquankhu1.vn
Ernexa Therapeutics Inc.Common Stock (NQ: ERNA - FinancialContent
Comparing Aditxt (NASDAQ:ADTX) & Ernexa Therapeutics (NASDAQ:ERNA) - Defense World
ERNA Technical Analysis & Stock Price Forecast - Intellectia AI
Eterna Therapeutics Updates Investor Presentation, Highlights Web Disclosure - The Globe and Mail
Ernexa Therapeutics updates investor presentation, posts Exhibit 99.1 on website - TradingView
Ernexa Therapeutics (NASDAQ: ERNA) furnishes new February 2026 investor presentation - Stock Titan
Ernexa Therapeutics (NASDAQ:ERNA) Trading Down 11.4% – Time to Sell? - Defense World
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series - GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Will Ernexa Therapeutics Inc. stock outperform value stocksQuarterly Growth Report & Fast Moving Stock Watchlists - mfd.ru
Insider Stock Purchases: February 18, 2026 - Quiver Quantitative
Ernexa therapeutics ten percent owner Cherington buys $2m in stock By Investing.com - Investing.com India
Ernexa therapeutics ten percent owner Cherington buys $2m in stock - Investing.com
ERNA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Will Ernexa Therapeutics Inc. outperform tech stocksJuly 2025 Chart Watch & Accurate Buy Signal Notifications - mfd.ru
Can Ernexa Therapeutics Inc. continue delivering strong returnsQuarterly Trade Review & Capital Efficiency Focused Strategies - mfd.ru
Will Ernexa Therapeutics Inc. stock remain a Wall Street favoriteWeekly Market Outlook & Short-Term High Return Ideas - mfd.ru
Will Ernexa Therapeutics Inc. stock benefit from green energy trendsTrade Volume Summary & Accurate Buy Signal Notifications - mfd.ru
Eterna Therapeutics Completes Public Offering to Bolster Capital - TipRanks
Ernexa Therapeutics Signs Multiple Financing Agreements - TradingView
Profit Review: Can Ernexa Therapeutics Inc. be recession proofWeekly Gains Report & Daily Momentum Trading Reports - mfd.ru
What hedge fund activity signals for Ernexa Therapeutics Inc. stockJuly 2025 PostEarnings & Target Return Focused Picks - mfd.ru
Total debt of Ernexa Therapeutics Inc. – NASDAQ:ERNAW - TradingView
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Ernexa Therapeutics prices $10.5 million public offering at $0.50 per share - Investing.com
Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering - The Manila Times
Ernexa Therapeutics Inc. Announces Pricing of $10.5 Million Public Offering of Common Stock and Warrants - Quiver Quantitative
Cancer cell therapy firm Ernexa prices $10.5M stock, warrant sale - Stock Titan
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Street Watch: Is Ernexa Therapeutics Inc forming bullish engulfing patternsQuarterly Investment Review & Reliable Entry Point Alerts - baoquankhu1.vn
Valuation Update: Why is Ernexa Therapeutics Inc stock going up2025 Volume Leaders & Proven Capital Preservation Methods - baoquankhu1.vn
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Ernexa Therapeutics Advances toward First-in-Human Trial for Ovarian Cancer Following Successful Pre-IND Meeting with FDA - Quiver Quantitative
Ernexa Therapeutics Participates in Virtual Investor “What - GlobeNewswire
Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA - Yahoo Finance
Japanese trade program selects Ernexa Therapeutics among elite biotech group - Investing.com Canada
Ernexa Therapeutics Selected for Japan Entry Acceleration Program to Advance Innovative Cell Therapies - Quiver Quantitative
Ernexa Therapeutics Selected as One of Only Ten Global - GlobeNewswire
New Highs: Can Ernexa Therapeutics Inc be recession proofEarnings Overview Report & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Can Ernexa Therapeutics Inc. be recession proofJuly 2025 News Drivers & Low Risk Entry Point Guides - baoquankhu1.vn
Top movers in Tuesday's after hours session - ChartMill
Breakout Zone: Is RICK showing insider buyingRisk Management & Growth Focused Investment Plans - baoquankhu1.vn
Ernexa Therapeutics Inc (ERNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):